Rapid access diagnostic pathway for suspected HF in primary care: The first 3 months... Dr Alan Japp Dr Sara Jenks Dr Clare McRae Dr Sebastian Peter.

Slides:



Advertisements
Similar presentations
Making a difference to Staying Healthy Jeff Seneviratne Joint Clinical Lead Chair, Biochemistry NAG GM Pathology Network.
Advertisements

Dorset Improving Diagnosis of Heart Failure Implementation of BNP Measuring in General Practice Ist Project Steering Group 13 th Sept 2011.
Diagnosing Heart Failure Sanjay Kumar Lead Consultant Cardiologist Grace Williams Lead Heart Failure Specialist Nurse Croydon Health Services NHS Trust.
Loop diuretics VS venous ultrafiltration in cardio-renal syndrome Radek Debiec SHO Renal Medicine LGH Sept 2013.
Management of Chronic Heart Failure SIGN 95
The Waikato Integrated Heart Failure Service (WIHFS) Debbie Chappell CNS Heart Failure Taumarunui/Te Kuiti/Otorohanga/Te Awamutu.
Evaluation of a community based heart failure programme. Authors. Anita Bell, Public Health Physician Veronique Gibbons, Research Fellow in Primary Care.
Indication:  Suspected Heart Failure With abnormal ECG or Intermediate BNP ( ) BNP:  Asymptomatic Murmur  Asymptomatic Cardiomegaly On CXR Direct.
Background, recognition and differentials. By Dr L Axten.
Locally Agreed Guidelines May Reduce Inappropriate Preoperative Echocardiography Requests Dr Sheila Carey Anaesthetic SpR Northern Deanery.
Cardiology Clinical Assessment & Treatment Service …coming soon!
Heart Failure: a community-based diagnostic clinic & service
Jennifer Bell British Heart Foundation Heart Failure Nurse Specialist.
Audit of Nurse Led Triage of Cardiology Referrals Fiona Smith Cardiology Nurse Wrexham Maelor hospital.
Heart Failure Audit Dr Jenny Welstand Lead Nurse Heart Failure Service Wrexham Maelor Hospital Acknowledgements: North Wales Cardiac Network Dr Richard.
NTproBNP for the Exclusion of Heart Failure Richard Blakey.
1 Improving cardiology referrals from primary to secondary care INTERIM PROJECT REPORT - July 2010 Armon Daniels, Lead GP Mags Moss, Cardiac Specialist.
WELCOME BNP testing. Aims of this education package Better understanding of what BNP testing is How to appropriately use the test How to request the.
HF diagnosis: audit of NTproBNP uptake and outcomes across Sheffield An update on diagnosis and management of HF Dr Abdallah Al-Mohammad, MD, FRCP(Edin),
ONE YEAR EXPERIENCE OF A “ SAFETY NET” PROTOCOL FOR ABNORMAL CHEST RADIOGRAPHS (CXR) H Singh, SCO Taggart, PM Turkington, K Peplow, R Chisholm, BR O’ Driscoll.
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
Physical Health and People with a Severe Mental Illness
National Clinical Pathway for suspected and confirmed lung cancer:
Lothian Heart Failure Diagnostic Pathway
Clinical Knowledge Summaries CKS Heart failure - chronic
Chronic heart failure By Vishal Patel GPVTS1.
Evaluation of CT Coronary Angiography (CTCA) and Cardiac Magnetic Resonance (CMR) in patients presenting with Acute Chest Pain (ACP) at A&E Background.
Dr P Purcell Dr J Orme October 2009 Carmarthenshire Division
DIAGNOSIS No symptoms = no heart failure. DIAGNOSIS No symptoms = no heart failure.
Guideline: Chronic Heart Failure
CTC Clinical Strategy and Cost Committee
Brian Crownover, MD, FAAFP Nellis FMR
Catriona Clark and Clare MacRae
Evaluation of Patients with chest pain Admitted under General Medicine; Has clinical judgment being taken over by serial troponins? Dr. Samantha Herath.
Community Cardiology Service North Wales 2017
Cwm Taf Community Cardiology AF / Palpitation Project
Jane E Scullion Respiratory Nurse Consultant
Quality of Referrals Guideline Congruence of referrals to TIAMS clinic
Echocardiograms in syncope work-up
Windhi Dwijanarko RSU DADI KELUARGA, PURWOKERTO
The Atrial Fibrillation Clinic in Llanelli
Stephen W. Waldo et al. JACC 2008;51:
Challenges Vision ‘How’ Objectives Outcome Aspirations
HEART FAILURE TEAM MEMBERSHIP
Cardiovacular Research Technologies
HEART FAILURE QUALITY & CLINICAL CARE PROGRAMME
Heart Failure Prevention: Mission Impossible?
Hyperemesis Care Pathway – Salisbury Hospital NHS Foundation Trust
Biomarker-Guided HF Therapy: Is It Cost-Effective?
20th Annual National Forum on Quality Improvement in Health Care
Time after discharge (days)
Overcoming Clinical Inertia
MK-0954 PN948 NOT APPROVED FOR USE (date)
Embargoed until 10:45 a.m. CT/11:45 a.m. ET Sunday, Nov. 11, 2018
Principal recommendations
Managing HF in Primary Care
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
Newly Diagnosed Type 2 Diabetes Mellitus
Lothian Heart Failure Diagnostic Pathway
NHS South Tees CCG Rapid Specialist Opinion (RSO)
Calculate Well’s score for PE (BOX1)
The Research Question Heart failure (HF) and atrial fibrillation (AF) frequently coexist and are associated with many adverse outcomes HF and AF share.
Catriona Clark and Clare MacRae
Atlantic Cardiovascular Patient Outcomes Research Team
HF Definition. Why and How Should We Be Treating Patients With Heart Failure With Preserved Ejection Fraction?
Managing HF in Primary Care
Discharge Summaries Practical advice.
The Heart Failure Nurse Service
Principal recommendations
Presentation transcript:

Rapid access diagnostic pathway for suspected HF in primary care: The first 3 months... Dr Alan Japp Dr Sara Jenks Dr Clare McRae Dr Sebastian Peter

Suspected new heart failure in community Both entry criteria met? No Not eligible for pathway: Consider general cardiology referral Exertional or nocturnal dyspnoea: new-onset or major worsening No echo or cardio review (for dyspnoea) within last 12 months Yes Key referral info Previous MI Response to diuretics Orthopnoea / PND High JVP, ankle oedema CXR abnormalities Abnormal ECG (LBBB/Q waves/LVH/AF N.B. CXR and ECG helpful but not essential prior to referral 1. Send bloods from Heart Failure Diagnosis ICE 2. SCI Referral Heart Failure (NRIE, Cardiology) – please include key referral info GP Action

Suspected new heart failure in community Both entry criteria met? No Not eligible for pathway: Consider general cardiology referral Exertional or nocturnal dyspnoea: new-onset or major worsening No echo or cardio review (for dyspnoea) within last 12 months Yes Key referral info Previous MI Response to diuretics Orthopnoea / PND High JVP, ankle oedema CXR abnormalities Abnormal ECG (LBBB/Q waves/LVH/AF N.B. CXR and ECG helpful but not essential prior to referral 1. Send bloods from Heart Failure Diagnosis ICE 2. SCI Referral Heart Failure (NRIE, Cardiology) – please include key referral info GP Action

Heart Failure Team Action NT-proBNP indicated as a rule-out test NT-proBNP not indicated Yes NT-proBNP ≥125 pg/mL Attend HF Clinic (ECG/echo) No Other significant abnormality Normal ECG/echo LVSD HF team will discharge: consider referral for non-cardiac assessment Cardiologist & HF nurse review Cardiologist review

Referrals: 3/10/17 – 5/1/18 80 referrals in first 3 months (6-7 per week) 18 assessed as unsuitable for pathway:

Referrals: 3/10/17 – 5/1/18 80 referrals in first 3 months (6-7 per week) 18 assessed as unsuitable for pathway: 62 suitable patients: 52% female; mean age 74

HF team perspective Enthusiastic input from heart failure nurses: triaging; corresponding Significant workload and clinic pressure but manageable Unanticipated delay from referral to NTproBNP samples Cumbersome NTproBNP request process

Outcomes - Summary Of 62 suitable referrals: 3 admitted prior to evaluation through pathway 2 days (HF with superadded pneumonia and severe sepsis) 5 days (decompensated HF) 15 days (suspected HF but discharge diagnosis CVI) 1 died prior to evaluation (cause of death COPD; NT proBNP only marginally elevated) Several not yet completed pathway 41 (66%) initially triaged to NTproBNP test

Outcomes - Summary Of 55 patients who have come through pathway: 22 (40%) diagnosed with heart failure 12 LVSD 10 HF with preserved EF Time from referral to NTproBNP sample Average = 5 days 6 samples > 13 days Time from referral (with blood sample) to diagnosis (rule in or rule out of HF): Overall average = 21 days Patients diagnosed with HF = 19 days

Outcomes by NTproBNP: 1. Negative BNP (<125 pg/ml) N = 11 patients Mean time to diagnosis (rule out of HF) = 8 days No subsequent deaths or hospital admissions 4 referred for resp evaluation 1 referred to weight management programme 1 assessed and treated for possible DVT 1 referred for general cardiology opinion (?IHD) 1 diagnosed obesity and hypertension 1 oedema due to CCB and CVI

Outcomes by NTproBNP: 2. ‘Grey zone’ BNP (126-400 pg/mL) N = 8 patients (mean age = 81 years) No LVSD x2 patients with HEFPEF x6 non-HF diagnoses

Outcomes by NTproBNP: 3. High BNP (>400 pg/mL) N = 16 patients 12 patients (75%) diagnosed with HF 7 patients LVSD 5 patients HEFPEF (x1 constrictive pericarditis) 2 admitted to hospital pre-evaluation (>10,000) 1 patient severe aortic stenosis (TAVI 6 weeks)

Outcomes by NTproBNP: 4. No BNP test N = 18 patients 9 patients (50%) diagnosed with HF 5 patients LVSD 4 patients HEFPEF 1 admitted to hospital pre-evaluation

Incidence of LVSD / HEFPEF by NTproBNP category

Conclusions Promising preliminary data Probably sustainable! Negative BNP patients – no harm; alternative Ix Room to improve on time to HF diagnosis Consider increasing NTproBNP threshold?

Thanks HF Nurses (esp Janet Reid, Shirley Robertson) Dr Martin Denvir Biochemistry labs team Referring GPs!